Advanced Search
Contact | Corporate | Help

Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer

Sponsors:
  • Sarah Cannon Research Institute
  • Genentech
  • Eli Lilly and Company
Phases:
  • Phase II
IndicationsAcronym:
  • Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Drug: Pemetrexed
  • Procedure: Radiation therapy
Enrollment:
50

Additional information about NCT00402883.


SourceSolution © 2008-2012